The unbalanced balance of responsibilities between innovators and regulators: the JUUL saga as an example of a global trend

Sylvie Gallage-Alwis and Elias Boukachabine, Signature Litigation

According to the UNESCO Institute for Statistics, global spending on research and development (R&D) has recently reached a record high of almost US$1.7 trillion, with many countries setting national targets for R&D spending as a share of their gross domestic product. As a result of these massive investments, important innovations have been made in a wide variety of industrial sectors, including renewable energy, medicine – as we recently witnessed with the Covid-19 vaccines, artificial intelligence, metaverse, space transportation etc.